STOCK TITAN

Quantum-Si to Participate in Upcoming Investment Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Quantum-Si (Nasdaq: QSI), The Protein Sequencing Company™, has announced its participation in two upcoming investment conferences. CEO Jeff Hawkins will engage in fireside chat discussions at the UBS Global Healthcare Conference on November 13th at 8:45 AM PT and the Canaccord Medtech, Diagnostics & Services Forum in New York City on November 21st at 8:00 AM ET. Both events will be available via live and archived webcasts in the 'Investors' section of Quantum-Si's website under Events & Presentations.

Quantum-Si (Nasdaq: QSI), L'azienda di sequenziamento proteico™, ha annunciato la sua partecipazione a due prossime conferenze di investimento. Il CEO Jeff Hawkins parteciperà a conversazioni informali durante la Conferenza Globale sulla Salute UBS il 13 novembre alle 8:45 AM PT e al Forum Canaccord Medtech, Diagnostica e Servizi a New York il 21 novembre alle 8:00 AM ET. Entrambi gli eventi saranno disponibili tramite webcast dal vivo e registrati nella sezione 'Investitori' del sito web di Quantum-Si, sotto Eventi e Presentazioni.

Quantum-Si (Nasdaq: QSI), La Empresa de Secuenciación de Proteínas™, ha anunciado su participación en dos próximas conferencias de inversión. El CEO Jeff Hawkins participará en charlas informales en la Conferencia Global de Salud de UBS el 13 de noviembre a las 8:45 AM PT y en el Foro Canaccord Medtech, Diagnósticos y Servicios en Nueva York el 21 de noviembre a las 8:00 AM ET. Ambos eventos estarán disponibles a través de transmisiones web en vivo y grabadas en la sección 'Inversores' del sitio web de Quantum-Si, bajo Eventos y Presentaciones.

Quantum-Si (Nasdaq: QSI), 단백질 염기서열 분석 회사™,는 두 차례의 투자 회의에 참여한다고 발표했습니다. CEO 제프 호킨스는 11월 13일 오전 8:45 PT에 UBS 글로벌 헬스케어 회의에서 편안한 대화에 참여하고, 11월 21일 오전 8:00 ET에 뉴욕에서 열리는 캐너코드 메드텍, 진단 및 서비스 포럼에 참석할 예정입니다. 두 행사 모두 Quantum-Si 웹사이트의 '투자자' 섹션에서 이벤트 및 발표 아래 생중계와 녹화된 웹캐스트로 제공됩니다.

Quantum-Si (Nasdaq: QSI), La Société de Séquençage Protéique™, a annoncé sa participation à deux prochaines conférences d'investissement. Le PDG Jeff Hawkins participera à des discussions informelles lors de la Conférence Mondiale sur la Santé UBS le 13 novembre à 8h45 PT et au Forum Canaccord Medtech, Diagnostics et Services à New York le 21 novembre à 8h00 ET. Les deux événements seront disponibles par le biais de webdiffusions en direct et archivées dans la section 'Investisseurs' du site Web de Quantum-Si sous Événements & Présentations.

Quantum-Si (Nasdaq: QSI), Das Unternehmen für Protein-Sequenzierung™, hat seine Teilnahme an zwei bevorstehenden Investitionskonferenzen angekündigt. CEO Jeff Hawkins wird am 13. November um 8:45 Uhr PT an informellen Gesprächen auf der UBS Global Healthcare Conference teilnehmen und am 21. November um 8:00 Uhr ET beim Canaccord Medtech, Diagnostics & Services Forum in New York City. Beide Veranstaltungen werden über Live- und Archiv-Webcasts im Bereich 'Investoren' der Quantum-Si-Website unter Veranstaltungen & Präsentationen verfügbar sein.

Positive
  • None.
Negative
  • None.

BRANFORD, Conn.--(BUSINESS WIRE)-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced that it will be participating in two upcoming investment conferences.

Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat discussion at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.

On Thursday, November 21st at 8:00 AM ET, Mr. Hawkins will participate in a fireside chat discussion at the Canaccord Medtech, Diagnostics & Services Forum in New York City.

A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.

About Quantum-Si Incorporated

Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company’s Platinum® instrument enables Next-Generation Protein Sequencing™ that advances proteomic research, drug discovery, and diagnostics beyond what has been possible with existing proteomic tools. Learn more at quantum-si.com or follow us on LinkedIn or X.

Investor Contact

Doug Farrell, VP, Investor Relations

ir@quantum-si.com

Media Contact

Katherine Atkinson, SVP of Commercial Marketing

media@quantum-si.com

Source: Quantum-Si Incorporated

FAQ

When is Quantum-Si (QSI) presenting at the UBS Global Healthcare Conference?

Quantum-Si (QSI) will present at the UBS Global Healthcare Conference on Wednesday, November 13th, at 8:45 AM PT.

Where can I watch Quantum-Si's (QSI) investment conference presentations?

The presentations can be viewed via live and archived webcasts in the 'Investors' section of Quantum-Si's website under Events & Presentations.

What investment conferences is Quantum-Si (QSI) attending in November?

Quantum-Si is attending the UBS Global Healthcare Conference on November 13th and the Canaccord Medtech, Diagnostics & Services Forum on November 21st.

What time is Quantum-Si's (QSI) presentation at the Canaccord Forum?

Quantum-Si will present at the Canaccord Medtech, Diagnostics & Services Forum on November 21st at 8:00 AM ET in New York City.

Quantum-Si Incorporated

NASDAQ:QSI

QSI Rankings

QSI Latest News

QSI Stock Data

190.76M
97.95M
19.85%
36.12%
4.15%
Medical Devices
Measuring & Controlling Devices, Nec
Link
United States of America
BRANFORD